ESC Professional Premium Access

Quality of life (QoL) in patients with heart failure with preserved ejection fraction (HFpEF): a systematic review

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Jieling Chen

AstraZeneca BioPharmaceuticals, Gaithersburg (United States of America)
1 presentation
0 follower

5 more presentations in this session

Impact of age on the utility of CardioMEMs device to guide heart failure therapy: analysis of the National Readmissions Database

Speaker: Assistant Professor A. Briasoulis (Athens, GR)

Thumbnail

Determinants and prognostic impact of afterload mismatch after MitraClip implantation

Speaker: Doctor F. Angelini (Turin, IT)

Thumbnail

Heart failure with mildly reduced ejection fraction: not a mid-range prognosis

Speaker: Doctor J. Borges-Rosa (Coimbra, PT)

Thumbnail

The prognostic value of sleep disordered breathing and the hypoxemic burden in HFpEF patients

Speaker: Miss S. Mourmans (Maastricht, NL)

Thumbnail

Systemic microvascular response to insulin is associated with risk of heart failure with preserved ejection fraction in women with type 2 diabetes

Speaker: Doctor E. Dal Canto (Utrecht, NL)

Thumbnail

Access the full session

Chronic heart failure - HFpEF - HFrEF - HFmREF

Speakers: Doctor J. Chen, Assistant Professor A. Briasoulis, Doctor F. Angelini, Doctor J. Borges-Rosa, Miss S. Mourmans...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations